Prognostic evaluation of interim PET negative DLBCL patients: Can baseline and interim PET imaging with clinical indicators offer additional value?

被引:0
|
作者
Chen, Xi [1 ]
Sun, Xun [1 ,2 ]
Zhang, Yongxue [1 ]
An, Rui [3 ]
Lan, Xiaoli [1 ,2 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Nucl Med, Wuhan, Peoples R China
[2] Hubei Key Lab Mol Imaging, Wuhan, Peoples R China
[3] HUST, Tongji Med Coll, Union Hosp, Wuhan, Peoples R China
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
241610
引用
收藏
页数:3
相关论文
共 50 条
  • [21] Hodgkin lymphoma: a negative interim-PET cannot circumvent the need for end-of-treatment-PET evaluation
    Mesguich, Charles
    Cazeau, Anne-Laure
    Bouabdallah, Krimo
    Soubeyran, Pierre
    Guyot, Martine
    Milpied, Noel
    Bordenave, Laurence
    Hindie, Elif
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 175 (04) : 652 - 660
  • [22] Can We Improve the Predictive Value of Interim PET/CT Using a New Prognostic Model for Advanced Hodgkin Lymphoma?
    Dann, Eldad J.
    Bairey, Osnat
    Bar-Shalom, Rachel
    Mashiach, Tanya
    Barzilai, Elinor
    Korenberg, Abraham
    Akria, Luiza
    Tadmor, Tamar
    Filanovsky, Kalman
    Abadi, Uri
    Kagna, Olga
    Ruchlemer, Rosa
    Goldschmidt, Neta
    Horowitz, Netanel A.
    Lavie, David
    Ben-Yehuda, Dina
    Shpilberg, Ofer
    Paltiel, Ora B.
    BLOOD, 2016, 128 (22)
  • [23] High-risk interim PET negative patients in Hodgkin's lymphoma
    Meignan, Michel
    LANCET HAEMATOLOGY, 2016, 3 (10): : E449 - E450
  • [24] Quantitative analyses at baseline and interim PET evaluation for response assessment and outcome definition in patients with malignant pleural mesothelioma
    Lopci, Egesta
    Zucali, Paolo Andrea
    Ceresoli, Giovanni Luca
    Perrino, Matteo
    Giordano, Laura
    Gianoncelli, Letizia
    Lorenzi, Elena
    Gemelli, Maria
    Santoro, Armando
    Chiti, Arturo
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 (05) : 667 - 675
  • [25] Quantitative analyses at baseline and interim PET evaluation for response assessment and outcome definition in patients with malignant pleural mesothelioma
    Egesta Lopci
    Paolo Andrea Zucali
    Giovanni Luca Ceresoli
    Matteo Perrino
    Laura Giordano
    Letizia Gianoncelli
    Elena Lorenzi
    Maria Gemelli
    Armando Santoro
    Arturo Chiti
    European Journal of Nuclear Medicine and Molecular Imaging, 2015, 42 : 667 - 675
  • [26] The impact of baseline and interim PET/CT parameters on clinical outcome in patients with diffuse large B cell lymphoma
    Park, Silvia
    Moon, Seung Hwan
    Park, Lee Chun
    Hwang, Deok Won
    Ji, Jun Ho
    Maeng, Chi Hoon
    Cho, Su-Hee
    Ahn, Hee Kyung
    Lee, Ji Yean
    Kim, Seok Jin
    Choi, Joon Young
    Kim, Won Seog
    AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (09) : 937 - 940
  • [27] Prognostic value of interim PET/CT in GCB and non-GCB DLBCL: comparison of the Deauville five-point scale and the ΔSUVmax method
    Sun, Na
    Qiao, Wenli
    Wang, Taisong
    Xing, Yan
    Zhao, Jinhua
    BMC CANCER, 2024, 24 (01)
  • [28] THE PREDICTIVE VALUE OF INTERIM PET-CT IN ELDERLY PATIENTS WITH HODGKIN LYMPHOMA
    Bentur, O. S.
    Eldad, D. J.
    Paran, E.
    Lavie, D.
    Nachmias, B.
    Dally, N.
    Gutwein, O.
    Herishanu, Y.
    Sarid, N.
    Perry, C.
    Avivi, I.
    HAEMATOLOGICA, 2017, 102 : 460 - 461
  • [29] The Value of Qualitative and Quantitative Evaluation of Interim-PET/CT in Lymphoma Patients For The Prediction of Metabolic Response
    Sahin, O.
    Serdengecti, M.
    Kaya, B.
    Dsmailoglu, M.
    Guler, T.
    Varoglu, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S373 - S373
  • [30] FIRST RESULTS OF A PROSPECTIVE EVALUATION OF INTERIM PET IN PATIENTS WITH DLBCL TREATED WITH R-CHOP-14 (SAKK 38/07)
    Mamot, C.
    Klingbiel, D.
    Bargetzi, M.
    Renner, C.
    Hitz, F.
    Pabst, T.
    Mey, U.
    Herrmann, R.
    Pless, M.
    Schaedler, M.
    Hany, T.
    Zucca, E.
    Martinelli, G.
    ANNALS OF ONCOLOGY, 2011, 22 : 157 - 158